ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0460

Cartilage Damage or (sub)luxation of Finger Joints: Impact on Physical Function in Patients with Rheumatoid Arthritis

Takehisa Ogura1, Yasuto Minegishi2, Chihiro Imaizumi1, Reina Maezawa1, Takaharu Katagiri1 and Hideto Kameda1, 1Toho university, Tokyo, Japan, 2Toho University, Tokyo

Meeting: ACR Convergence 2024

Keywords: cartilage, HAQ, rheumatoid arthritis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: It has been reported that radiographic joint space narrowing (JSN) score affects the health assessment questionnaire-disability index (HAQ-DI) score in rheumatoid arthritis (RA) patients. However, it has not been determined whether cartilage damage or (sub)luxation of small joints predominantly affects the HAQ-DI score. Therefore, we directly evaluated cartilage damage by ultrasonography (US) in addition to radiographic JSN score, and examined their impact on HAQ-DI score.

Methods: Patients with RA in disease activity score (DAS) 28-C-reactive protein (CRP) ≤3.2 were evaluated using the HAQ-DI, the JSN score of the modified total Sharp score by radiographic examination of the bilateral metacarpophalangeal joints and proximal interphalangeal joints of the second to fifth fingers, the presence of dislocation or subluxation, and cartilage by US using a semiquantitative score with a 3-point scale from 0-2. The total score of 16 joints was calculated as the JSN score (maximum score; 64) and US score (maximum score; 32), respectively. HAQ-DI ≤ 0.5 was defined as functional remission, and the functional remission group and non-remission group were compared. Furthermore, logistic regression analysis was performed to include age, gender, disease duration, DAS28-CRP, Body Mass Index, and use of biological disease-modifying antirheumatic drugs (bDMARDs) as explanatory variables for functional remission based on previous studies and univariate analysis.

Results: A total of 101 patients were included. Median age, disease duration, and DAS28-CRP were 64 years, 5.8 years, and 1.71, respectively. The median HAQ-DI was 0.12, and 78 patients (77%) achieved the remission criteria. Comparing function remission and non-remission groups, the remission group was significantly younger and had lower DAS28-CRP, but there was no significant difference in disease duration (Table 1). There were no significant differences in JSN and US scores, and radiographs showed more (sub)luxations in the non-remission group (12% vs. 30%, p=0.047). In the model, including the JSN score (model 1) and US score (model 2), respectively, both JSN score and US score had no significant effect on functional remission, with odds ratios of 0.98 (p=0.50) and 1.02 (p=0.78), respectively (Table 2). However, when the US score and the presence of (sub)luxation were included (model 3), the odds ratio for the presence of (sub)luxation was 0.19 (p=0.048), and it was an independent factor that prevented the achievement of functional remission along with DAS28-CRP.

Conclusion: This study indicates that (sub)luxation of small joints, rather than cartilage damage, affect physical function in RA patients.

Supporting image 1

Table 1. Patient characteristics and imaging findings

Supporting image 2

Table 2. Multivariate analysis of the factors associated with functional remission


Disclosures: T. Ogura: AbbVie/Abbott, 6, Asahikasei, 6, Bristol-Myers Squibb(BMS), 6, Eisai, 6, Eli Lilly, 6, Janssen, 6, Mitubishi Tanabe, 6, Novartis, 6, Pfizer, 6, Taisho, 6; Y. Minegishi: None; C. Imaizumi: None; R. Maezawa: None; T. Katagiri: None; H. Kameda: AbbVie GK, 2, 5, 6, Asahi-Kasei, 2, 5, 6, Boehringer Ingelheim GmbH, 2, 5, 6, Bristol-Myers Squibb, 2, 6, Chugai, 2, 5, 6, Eisai, 5, Eli Lilly Japan K.K., 2, 6, Janssen K.K., 2, 6, Mitsubishi-Tanabe, 2, 5, 6, Novartis, 2, 6, Pfizer Japan, 2, 6, Sanofi K.K., 2, 6, Taisho, 5, UCB Japan, 2, 6.

To cite this abstract in AMA style:

Ogura T, Minegishi Y, Imaizumi C, Maezawa R, Katagiri T, Kameda H. Cartilage Damage or (sub)luxation of Finger Joints: Impact on Physical Function in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/cartilage-damage-or-subluxation-of-finger-joints-impact-on-physical-function-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cartilage-damage-or-subluxation-of-finger-joints-impact-on-physical-function-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology